KEY TRENDS • Oxfam India's 2023 India Supplement report on poverty and inequality in India reveals that the gap between the rich and the poor is widening. Following the pandemic in 2019, the bottom 50 per cent of the population have continued to see their wealth chipped away. By 2020, their income share was estimated to have fallen to only 13 per cent of the national income and have less than 3...
More »SEARCH RESULT
Total Matching Records found : 181
Voluntary Licensing Agreements between MPP and Big pharma – Increasing Monopoly Power -Richa Chintan
-Newsclick.in The recent agreements between Medicine Patent Pool and Big pharma are being projected as benevolent gestures from pharma companies in sharing their patented technologies with other countries. The fact is it is working towards cementing its monopoly power further. The development of anti-viral oral pills to combat COVID-19 will, hopefully, make the fight against the pandemic more promising. While Merck has developed the anti-viral pill Molnupiravir, Pfizer has come up with...
More »TRIPS Waiver Proposal: Big pharma Steering Discourse Away From Patent Monopoly -Richa Chintan
-Newsclick.in It appears the stage is being set to scuttle India and South Africa’s IP waiver proposal with regard to Covid vaccines and technology ahead of the 12th WTO Ministerial this month-end. At various global fora, Big pharma and rich countries have been steadfastly pushing the focus toward supply-side bottlenecks of vaccines and unequal distribution of doses in a bid to steer the discourse away from the more contentious issue of patents...
More »Big pharma– Maximum Earnings, Minimum Responsibilities -Richa Chintan
-Newsclick.in The pandemic has again exposed the true nature of capitalism with profit being the primary driver irrespective of the rising inequalities. The contrast between the devastating effects of the Covid-19 pandemic on the lives and livelihood of the working-class population and the soaring profits of Big pharma companies in the corresponding period is abhorrent. Please click here to read more. ...
More »COVID Vaccines: Where Does India Truly Stand on the TRIPS Waiver? -Priti Patnaik
-TheWire Science * The Indian government has consistently discouraged compulsory licenses on generic drugs. * One of the big questions the India government has not answered is why it isn’t using pharma PSUs to produce drugs and vaccines. * Not one member of Indian industry is willing to stand up and fight for compulsory licenses, and for patients, says lawyer Murali Neelakantan. India has played a crucial role in supporting South Africa, as a...
More »
